News and Trends 18 Apr 2024
Biotech under surveillance: The global impact of the WuXi AppTec controversy
Delve into the ongoing controversy involving the Chinese company WuXi AppTec and the possible impact on U.S. national security measures.
CDMO
- Latest Posts
Expert Advice 5 Apr 2024
How to build a career as an investigator at the FDA?
Discover the role and implications of an FDA investigator, a career of high responsibility and challenges, from qualifications to application.
In Depth 27 Feb 2024
Can the Novo Holdings-Catalent deal set a new standard for Pharma M&A?
Explore the strategic implications of Novo Nordisk’s $16.5B Catalent acquisition on drug supply and market competition.
Why Fina Biosolutions partnered with Scorpius BioManufacturing for cGMP production of EcoCRM® (CRM197)
Explore Fina Biosolutions’ alliance with Scorpius BioManufacturing, driving affordability in global conjugate vaccine production.
Mastering biologics tech transfer: key success factors
Unlock the secrets of efficient tech transfers for biologics, and explore critical stages and success factors.
How to select the right CDMO for innovative antibody development
ADVERTISEMENT
ADVERTISEMENT
Infographic: Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects
In 2021, 28% of FDA approvals were granted to biologic drugs, showcasing the increasing demand for the biopharma industry to develop, manufacture and market biologic-based therapies. Biologic drugs include monoclonal antibodies and large molecules produced in mammalian cells, bringing the already complex process of drug development to a new level. Although the biomanufacturing of many […]
News and Trends 9 Feb 2023
Icosagen receives €18M loan for R&D and new facility
The Estonian biopharma company Icosagen AS has reached an €18 million financing agreement with the European Investment Bank (EIB) backed by the InvestEU program. The funds will strengthen the company’s drug discovery, development and production services. The funds are part of Icosagen’s €40 million investment into increasing its innovative contract research and development capabilities as […]
News and Trends 11 Jan 2023
Five key trends shaping life sciences in 2023
By Kevin Wayer, president – government, education, infrastructure and life sciences industries, JLL, and Travis McCready, head of life sciences, industries Americas, JLL After an unprecedented period of growth during the pandemic, life sciences activity normalized in 2022. The life sciences industry has not been immune to the macroeconomic challenges plaguing the global economy, but […]
News and Trends 8 Nov 2022
GHO Capital and Vistria Group to acquire CDMO Alcami
Global Healthcare Opportunities, (GHO Capital Partners LLP), and The Vistria Group, have entered into a definitive agreement to acquire a controlling interest in Alcami Corporation, a pharmaceutical contract development and manufacturing organization (CDMO), from funds affiliated with Madison Dearborn Partners (MDP) and Ampersand Capital Partners. Headquartered in North Carolina, Alcami is involved in drug product […]
News and Trends 26 Oct 2022
ABL and RD-Biotech to partner on cell and gene therapy manufacturing
French companies ABL and RD-Biotech have signed a strategic partnership to cover cell and gene therapy (C>) GMP manufacturing. ABL, is a contract development and manufacturing organization (CDMO) that specializes in the development and manufacturing of solutions for biopharma, including viruses for gene therapies, oncolytic viruses and vaccine candidates. RD-Biotech is a CRO (contract research […]
ADVERTISEMENT